Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Tokyo VD who wrote (3946)	5/6/1998 11:43:00 AM
From: Linda Kaplan	Respond to of 7041

Tokyo: Now, that's amusing! I bet Zonagen would also like to see a combination with De Beers. Diamond studded (ahem) Vasomax must have a lot of petential. One could give the engagement ring along with the Vasomax pill and if they also combine with an airlines, they can include one of the little bags to take care of any side effects. Zonagen would love a combination with Viagra. So far there's no indication that Vasomax does much of anything, so why would PFE want to dilute Viagra by combining it with a drug that doesn't do much of anything? It's part of the Zonagen hype to talk about vague combinations with other drugs, not name them or actually give the results, and a test group of TEN subjects! What sophistry. I suppose with the drop out rate they have in their studies, they'd have been left with 3 subjects and would call the results statistically significant. Seems like there's a sucker born every minute, though. The company's got nothing and the stock's going up. LOL! Linda

To: Tokyo VD who wrote (3946)	5/6/1998 12:59:00 PM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

I found a long lost study by Zonagen! Two normal male Mexicans were asked to take 40mg Vasomax with 81mg aspirin on three occasions. One subject moved to LA and had to be removed from the study group. The one remaining reported no headaches during sex on two of the three trials. Zonagen's CEO says, "We feel these results are statistically sigificant on the Pinoccio scale and indicative of a promising future business arrangement between Bayer and Zonagen." Linda